article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

In many European countries physicians can now prescribe medical cannabis for an array of chronic health conditions, including chronic pain, mental health disorders and neurological conditions. 1 In many countries, medical cannabis is only utilised as a therapy when licensed medications have proven ineffective. Just an excuse?

Medical 86
article thumbnail

Clinical Overview: Potentially Harmful Medications in Heart Failure

Pharmacy Times

An average patient with heart failure can take up to 6 medications for guideline-directed medical therapy; however, they may have other comorbidities that require pharmacologic management.

Medical 49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Role of Certifications in Advancing Your Career in Medical Sales

Rep-Lite

In medical sales, advanced certifications are crucial in demonstrating specialized knowledge of products, regulations, and market trends. Enhanced Expertise and Knowledge Advanced certifications in medical sales provide sales professionals with specialized knowledge and expertise that go beyond basic training.

article thumbnail

Chiesi joins with Aptar on digital platform for respiratory patients

pharmaphorum

Hard on the heels of the official launch of its digital disease management platform, Aptar Pharma has secured a partnership with Italian drugmaker Chiesi to deploy it in support of patients. The post Chiesi joins with Aptar on digital platform for respiratory patients appeared first on. billion of its total revenues of €2.4

article thumbnail

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Legacy MEDSearch

“At Cala, we’ve always been committed to expanding patient access and accelerating innovation in TAPS therapy for indications beyond essential tremor,” said Renee Ryan, CEO at Cala. “By By expanding into Parkinson’s disease, we are now able to bring this powerful treatment to additional patients who suffer from action hand tremors.”

article thumbnail

MHRA Chief Executive to step down

European Pharmaceutical Review

[While she is stepping down from her current role, Dame June shared that she still hopes to contribute] “to patient safety and public health in other ways” “It has been an enormous privilege to have led the MHRA through a time of change which is unprecedented in UK medical products regulation.

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7

Patients 101